The global #cns_therapeutics_market is growing substantially due to innovation in treating neurological and psychiatric disorders, increasing from USD 123.7 billion in 2025 to an expected USD 184.5 billion by 2033, with a CAGR of 5.3%.
Read More:
https://m2squareconsultancy.co....m/reports/c-reactive